Implantica publishes Interim Report January – September 2024 (Q3)

VADUZ, Liechtenstein, Nov. 15, 2024 /PRNewswire/ — RefluxStop™ achieves crucial FDA milestone and leaps forward with strong momentum in both the US and Europe Significant events in the third quarter of 2024 First national RefluxStop™ user meetings took place in Italy and Spain with over…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.